insights_auto
Why is MGX down 7,69%?
Dive Deeperchevron_right
MGX:NASDAQ
Metagenomi Therapeutics Inc
US$1,02
arrow_downward
-7,69%(-0,085) 1D
2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MGX...
Open
US$1,09
High
US$1,10
Low
US$1,02
Mkt. cap
38,36 ລ້ານ
Avg. vol.
149,22 ພັນ
Volume
0,00
52-wk high
US$3,95
52-wk low
US$1,02
EPS
US$-2,49
Shares outstanding
37,78 ລ້ານ
No. of employees
113
Open
US$1,09
High
US$1,10
Low
US$1,02
Mkt. cap
38,36 ລ້ານ
Avg. vol.
149,22 ພັນ
Volume
0,00
52-wk high
US$3,95
52-wk low
US$1,02
EPS
US$-2,49
Shares outstanding
37,78 ລ້ານ
No. of employees
113
News stories
From web sources and news partners
PennLive.com
·
1 ຊົ່ວໂມງກ່ອນ
Nasdaq-listed tech company names Pa. county as site for big data center campus in the works
Simply Wall Street
·
4 ນາທີກ່ອນ
We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully
PR Newswire UK
·
32 ນາທີກ່ອນ
Solidion Technology (NASDAQ: STI) Remains Firm on Flux Power (NASDAQ: FLUX) Below Market Offer in Response to Flux Board Rejection
Reuters
·
2 ຊົ່ວໂມງກ່ອນ
Panmure Liberum forecasts S&P 500 falling to 5,000, warns bull run nearing end
About Metagenomi Therapeutics Inc
CEO-
Employees113
Founded2016
HeadquartersEmeryville, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitemetagenomi.co